Correlation Between Ocuphire Pharma and Fortress Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ocuphire Pharma and Fortress Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ocuphire Pharma and Fortress Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ocuphire Pharma and Fortress Biotech, you can compare the effects of market volatilities on Ocuphire Pharma and Fortress Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ocuphire Pharma with a short position of Fortress Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ocuphire Pharma and Fortress Biotech.

Diversification Opportunities for Ocuphire Pharma and Fortress Biotech

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Ocuphire and Fortress is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Ocuphire Pharma and Fortress Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fortress Biotech and Ocuphire Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ocuphire Pharma are associated (or correlated) with Fortress Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fortress Biotech has no effect on the direction of Ocuphire Pharma i.e., Ocuphire Pharma and Fortress Biotech go up and down completely randomly.

Pair Corralation between Ocuphire Pharma and Fortress Biotech

Given the investment horizon of 90 days Ocuphire Pharma is expected to generate 0.7 times more return on investment than Fortress Biotech. However, Ocuphire Pharma is 1.43 times less risky than Fortress Biotech. It trades about -0.02 of its potential returns per unit of risk. Fortress Biotech is currently generating about -0.02 per unit of risk. If you would invest  308.00  in Ocuphire Pharma on August 29, 2024 and sell it today you would lose (195.00) from holding Ocuphire Pharma or give up 63.31% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.56%
ValuesDaily Returns

Ocuphire Pharma  vs.  Fortress Biotech

 Performance 
       Timeline  
Ocuphire Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ocuphire Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest inconsistent performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.
Fortress Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fortress Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Fortress Biotech is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Ocuphire Pharma and Fortress Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ocuphire Pharma and Fortress Biotech

The main advantage of trading using opposite Ocuphire Pharma and Fortress Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ocuphire Pharma position performs unexpectedly, Fortress Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Biotech will offset losses from the drop in Fortress Biotech's long position.
The idea behind Ocuphire Pharma and Fortress Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins